MLN news archive

45 stories

Last checked

Refresh

Estimated news impact scores by coin. Scores are not price-change percentages. High impact means a score of +70 or more, or -70 or less.

  1. Published Social post

    Enzyme (@enzymefinance)

    Enzyme is joining @RaylsLabs as a launch partner 💪 Onyx & Myso will be live on Rayls from day one. Institutional-grade tokenized fund infrastructure, ready from the start. Read more: https://enzyme.finance/blog-posts/enzyme-arrives-on-rayls

  2. Published Social post

    Enzyme (@enzymefinance)

    Private credit is moving on-chain. Loan mechanics, collateral management, settlement flows... all enforced on-chain with full compliance controls. @credilabs and @turtledotxyz launched exactly that, built on Enzyme. 👇

  3. Published Social post

    Enzyme (@enzymefinance)

    MiCA has been on everyone's radar for a while but actual approvals have been slow. Seeing a bank of ClearBank's size get through it signals that the regulatory path in Europe is becoming more concrete for the whole industry. For anyone building tokenized fund infrastructure in Europe, Enzyme is already MiCA-ready. Happy to walk through what that looks like in practice.

  4. Published Social post

    Enzyme (@enzymefinance)

    Did you know you can now use @Ledger to run a hedge fund? Passif runs its delta-neutral hedge fund fully on-chain through Enzyme Onyx, executing its decentralized strategy using Ledger Wallet. Read the full story: https://www.enzyme.finance/blog-posts/deploying-a-fully-decentralized-hedge-fund-with-enzyme-onyx?utm_source=x&utm_medium=organic&utm_content=post https://t.co/fYOzDFs72y

  5. Published Social post

    Enzyme (@enzymefinance)

    How Diva Staking DAO raised $62M in TVL pre-launch 💡 With Enzyme​.Blue, they deployed an Early Staker Vault in days with branded vault pages, and transparent rewards without dev overhead. Result: $62M deposits + seamless LP experience. https://enzyme.finance/products/blue?utm_source=x&utm_medium=organic&utm_content=post https://t.co/jNGM7ROwNA

  6. Published Social post

    Enzyme (@enzymefinance)

    Everybody builds, but what's the next step? ➡️@staderlabs used Enzyme Vaults to launch their ETHx Hyperloop. ➡️@swissborg introduced the Hyperloop to their 800K+ users, reaching max cap in days! Ready to do the same? Let’s have a chat →http://enzyme.finance/contact-us https://t.co/t33aUnH4vD

  7. Published Social post

    Enzyme (@enzymefinance)

    Asset managers told us exactly what they need to bring the next wave of finance onchain: “I want to build and manage cross-chain strategies, not just on one network.” “I need access to any protocol such as DeFi, CEXs, banks, you name it.” “I want to work with any asset, from crypto and NFTs to stocks and RWAs.” So, we built Enzyme.Onyx. Enzyme.Onyx is the wallet tokenization layer for unrestricted, institutional-grade asset management. Three ways we’re solving the industry’s biggest challenges: ① True cross-chain execution: Run strategies seamlessly across blockchains, with all activity and assets consolidated at the vault layer. ② Unrestricted protocol access: Use your Enzyme.Onyx vault to interact with DeFi, CEXs, banks, brokers… no limits. ③ Universal asset support: Reflect, manage, and report on any financial instrument like crypto, NFTs, RWAs, stocks, bonds, etc. directly in your vault. Enzyme.Onyx is built for the innovators designing tomorrow’s global funds and programmable finance products. Explore what’s possible: https://t.co/khpikdKbHe

  8. Published Social post

    Enzyme (@enzymefinance)

    Incredible to see Enzyme.Myso v3 hit $40M+ in notional settled this year, a record 8x growth in just three months! 🧬 Huge thanks to our community, partners, and everyone exploring what’s possible with Enzyme. Quote [@Mona_El_Isa](https://www.twitter.com/Mona_El_Isa/status/1946915329340522965) > 8x growth unlocked by Enzyme.Myso! 📈 > > Super excited to share a big milestone, Enzyme.Myso v3 has now crossed $40M+ in YTD notional volume (a record 8x growth in three months), with $1.5M+ in premiums paid to users and $172K in protocol fees. 💪 > > What’s even more exciting: we’re… https://t.co/K027OHzGcO

  9. Published Social post

    Enzyme (@enzymefinance)

    Another milestone for Enzyme.Myso - After crossing $20M in notional just weeks ago, we’ve now reached $1.20M+ in premiums 📈 Here’s where we stand today: • $1.20M+ in total premiums • $33M+ in notional volume • 7× growth over the past 90 days As demand for structured strategies accelerates, Enzyme.Myso is becoming the go-to execution layer for tokenized options and yield. Explore: https://t.co/8oy6LHlQ1O

  10. Published Social post

    Enzyme (@enzymefinance)

    The question is no longer if tokenized funds will scale, it’s how far they’ll go. According to @Citi, tokenized securities could grow into a $4–5T market by 2030. The World Economic Forum (@wef) estimates that 10% of global GDP could be tokenized and stored on the blockchain by 2027. As we look toward the next decade, the financial system is undergoing a structural rewrite. Since traditional funds face pressure from outdated infrastructure and rising operational costs, tokenized vehicles offer an alternative that’s programmable, composable, and globally accessible. From ETFs and term deposits to structured products and debt instruments, financial logic is moving onchain. In the next cycle, we expect to see: • A big shift towards natively tokenized funds rather than tokenization of existing layers • More institutional experimentation with onchain funds • A new generation of asset managers building directly into DeFi infrastructure • Policy shifts enabling greater clarity and adoption of onchain vehicles Enzyme is built to support this shift with the flexibility to design tokenized strategies natively or bring existing products onchain. Explore the infrastructure behind tomorrow’s fund models → https://t.co/B6hYeELfmM

  11. Published Social post

    Enzyme (@enzymefinance)

    Glad to support @auroraisnear's marketplace with Enzyme.Onyx by offering chain builders a wallet tokenization layer to strengthen liquidity and drive long-term TVL through bespoke incentivized pools.

  12. Published Social post

    Enzyme (@enzymefinance)

    Enzyme.Myso v3 just passed $16M in total notional volume. 📈 Launched earlier this year, the protocol is powering covered calls and cash-secured puts at scale, most recently a $1.2M call on $AAVE. It’ll only get bigger from here. Learn more → enzyme.finance/products/myso?…

  13. Published Social post

    Enzyme (@enzymefinance)

    Enzyme.Myso brings customizable on-chain options to DeFi, enabling secure, non-custodial creation, trading, and management of structured products. Tailor Covered Calls and Cash-Secured Puts to fit your objectives using customizable parameters, from strike prices and expiries to premium decay, auction floors, and delegation rules. Whether you’re a seller seeking instant yield or a trading firm looking to access institutional-grade structured products, Enzyme.Myso enables secure, non-custodial on-chain settlement with: ✅ A broad ERC-20 asset universe ✅ Automated Matchmaking through our universal marketplace ✅ OTC with direct access to cross-firm liquidity ✅ Compatibility with any EVM network Explore the full suite of use cases and start writing on-chain options today: 🧬 https://t.co/Q0abhvRDUL

  14. Published Social post

    Enzyme (@enzymefinance)

    Enzyme 🤝 @arbitrum Did you know that you can create and manage tokenized products & strategies on #Arbitrum using Enzyme​.Blue? Whether you're building funds, financial instruments, pools or else, it's all live, fast, and customizable. Proud to be on Arbitrum 💙🧡

  15. Published Social post

    Enzyme (@enzymefinance)

    Enzyme 🤝 @base Enzyme​.Blue, the all-around vault-as-a-service platform is now live on Base! From tokenized funds to financial instruments, projects can now tap into the Base ecosystem to deploy their strategies - fast and efficiently. Learn More ⬇️ 1/🧵

  16. Published Social post

    Enzyme (@enzymefinance)

    Enzyme​.Blue is here! Built for businesses and institutions, Enzyme​.Blue is the all-around Vault-as-a-Service platform to create and manage tokenized products. What you build is up to you. Blue makes it possible.

  17. Published Social post

    Enzyme (@enzymefinance)

    After months of dedication, we’re thrilled to announce the beta release of MYSO v3 🚀 - Create and sell bespoke covered calls to earn instant income - Trade calls seamlessly within our app - Integrate MYSO protocol into your project with ease More ⬇️

  18. Published Social post

    Enzyme (@enzymefinance)

    2025 : A NEW CHAPTER 🚀 As we wrap up 2024 and prepare for what promises to be the most pivotal year in Enzyme’s journey, we reflect on the exhilarating path we’ve traveled. In 2025, Enzyme steps into a new chapter, building on past successes to aim higher ⬇️ This milestone represents the culmination of tireless effort and dedication, solidifying Enzyme’s reputation as what our cherished community proudly calls an “OG.” Did you miss some episodes? Here’s a recap 📅 2017 — Enzyme is born as Melon Protocol. The mission? Equip on-chain asset managers with the right technology to simplify tokenized asset management. $MLN is launched. The journey begins! 2018 — The protocol launches on Testnet, and a DAO governance framework is established. 2019 — Our V1 goes live on Mainnet in February. 2020 — Despite a bear market, we keep building and celebrate the launch of V2. Melon Protocol rebrands to Enzyme, marking a significant evolution. 2021 — Development of V4, “Sulu,” begins with a strong focus on auditing. Unslashed becomes the first major protocol to leverage Enzyme for on-chain asset management vaults. 2022 — V4 “Sulu” goes live. The platform gains traction as numerous projects begin building on it, cementing Enzyme’s position as the go-to on-chain asset management platform. @NexusMutual becomes the second-largest protocol using Enzyme. 2023 — Development of V5 is underway. Enzyme expands its influence by powering regulated funds (e.g., @avantgardefi ) and supporting protocols like @divastaking , @swellnetworkio , and more. Here comes 2024, a year so full of milestones and breakthroughs that it would take 10 pages to cover it all. In summary, here’s a glimpse into what made this past year unforgettable: ➡️Enzyme officially separates from Avantgarde, ensuring a clear distinction between the two activities to better drive adoption. ➡️Appointment of a new COO and establishment of a full-time marketing function to accelerate growth and put things in motion to deliver our 2025 plan. ➡️Meeting fantastic people in Singapore, Abu Dhabi, Bangkok and more… ➡️ Extension of our protocol to @arbitrum and integration of @GMX_IO. ➡️First dip into BTCFi with @VaultCraft_io. ➡️Pushing the Staking space forward with @RenzoProtocol, @YieldNestFi and more… ➡️Launch of the first Advanced Automated Loops powered by Enzyme. Hyperloop by @staderlabs shows how Enzyme enables seamless access to advanced investment opportunities. ➡️Acquisition of @MysoFinance, the leading on-chain covered calls protocol, positioning Enzyme as a global infrastructure provider. ➡️Investment in @TradeNeutral to expand Enzyme’s services to the @solana ecosystem in 2025. And all of this, while continuing to develop v5 and enhancing v4 with adapter integrations like GMX and @pendle_fi, alongside expanding our asset universe. Enzyme wraps up an incredible 2024, with over 1,400 creations powered by our infrastructure and more than $220M in Assets Under Technology 🎉 These achievements reflect resilience, a steady hand in the face of challenges, and ambitions that reach beyond the short-term. It lays the perfect foundation to open this new chapter. We believe 2025 will be the year of convergence. At Enzyme, everything we do is aimed at pushing the boundaries of Decentralized Finance, with a vision of a world where decentralized solutions are as widely accepted as traditional instruments, showcasing their performance, elegance, and value in driving business, solving challenges, and reshaping the way we approach finance. How will we deliver on this vision? 🎯 Concretizing our extension to Solana. 🎯 Expanding to other key networks and breaking network barriers. 🎯 Broadening our global services, reinforcing our transition to a global infrastructure. 🎯 Capitalizing on innovative technologies that will set new standards for the industry. 🎯 Keeping on collaborating with innovative leaders in the space to promote and spread decentralized solutions — from iconic projects to helping emerging ones grow. We’re in this together! 🎯 Launching our v5, the most important protocol update to drive the adoption of on-chain asset management solutions. …and many more exciting updates that we can’t wait to share with you! Here’s to a magnificent 2024 and an incredible 2025 ahead!

  19. Published Social post

    Enzyme (@enzymefinance)

    5/ This exciting announcement is the latest in a series of strategic moves Enzyme has made to become a global infrastructure. We recently added new product lines through the acquisition of @MysoFinance and will keep on innovating. Way more to follow!

  20. Published Social post

    Enzyme (@enzymefinance)

    Yesterday, we announced that Enzyme, the leading on-chain asset management infrastructure, is extending its services to @solana through a strategic partnership with @TradeNeutral. What’s next, and why does it matter? Let’s dive in 🧵

  21. Published Social post

    Enzyme (@enzymefinance)

    Network compatibility is essential for the widespread adoption of on-chain asset management services. Enzyme is already available on @ethereum, @0xPolygon, and has recently integrated @arbitrum. But that’s not all! Stay tuned for an exciting announcement this Wednesday🚀

  22. Published Social post

    Enzyme (@enzymefinance)

    🚀 A few weeks ago, we announced that Enzyme is acquiring @MysoFinance, unlocking new seamless and innovative investment opportunities such as covered calls for our users. With MYSO’s exciting v3 update just around the corner, dive into our partnership to see what’s next! 👇

  23. Published Social post

    Enzyme (@enzymefinance)

    1/ We’re excited to announce that Enzyme is now available to Arbinauts 👩‍🚀👨‍🚀on @Arbitrum 💙 💙 and that we have secured three exciting launch partners; ARCrypto @arcrevolution_, dlcBTC @dlcBTC and Overnight Finance @overnight_fi

  24. Published Social post

    Enzyme (@enzymefinance)

    Enzyme is thrilled to announce our partnership with @31ThirdProtocol 🤝 Managers can now access advanced multi-asset trading capabilities: instantaneous multi-asset swaps, swift portfolio rebalancing and algorithmic smart order routing. 🔗 link.medium.com/Md6xZXjgwLb $MLN #DeFi

  25. Published Social post

    Enzyme (@enzymefinance)

    Last week, we announced Enzyme's new Modular Liquid Restaking As-a-Service for LRT projects. Now, let's take a closer look at @AngleProtocol's stUSD Restaking Vault, powered by Enzyme and @nektarnetwork. ⬇️⬇️⬇️ $MLN #DeFi #DeFiNews #Restaking #Web3 twitter.com/enzymefinance/… Quote [@enzymefinance](https://www.twitter.com/enzymefinance/status/1805601933878583467) > Introducing permissionless & modular liquid restaking, a new primitive powered by Enzyme & @NektarNetwork. > > We launch with @AngleProtocol’s stUSD Restaking Vault, @DLC_Link’s dlcBTC Bitcoin Staking Pool & @Re7Capital’s Nektar ETH Vault. > > 🔗 link.medium.com/m0bV34zzIKb > > ⬇️⬇️⬇️ > > $MLN

  26. Published Social post

    Enzyme (@enzymefinance)

    Today we are excited to formally announce Enzyme is powering @swellnetworkio's Super swETH Vault 🥳 Swell's Super swETH initiative rewards staking participants and helps decentralise the Ethereum staking ecosystem. 🔗 https://link.medium.com/gfTo8XcJLEb #DeFi #Staking #Ethereum $ETH

Showing 45 of 45 stories. Filters apply to the full news archive.